These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
485 related articles for article (PubMed ID: 10777207)
1. Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site. Takimoto R; El-Deiry WS Oncogene; 2000 Mar; 19(14):1735-43. PubMed ID: 10777207 [TBL] [Abstract][Full Text] [Related]
2. Decoy receptor 2 (DcR2) is a p53 target gene and regulates chemosensitivity. Liu X; Yue P; Khuri FR; Sun SY Cancer Res; 2005 Oct; 65(20):9169-75. PubMed ID: 16230375 [TBL] [Abstract][Full Text] [Related]
3. p53 upregulates death receptor 4 expression through an intronic p53 binding site. Liu X; Yue P; Khuri FR; Sun SY Cancer Res; 2004 Aug; 64(15):5078-83. PubMed ID: 15289308 [TBL] [Abstract][Full Text] [Related]
4. Evidence that the death receptor DR4 is a DNA damage-inducible, p53-regulated gene. Guan B; Yue P; Clayman GL; Sun SY J Cell Physiol; 2001 Jul; 188(1):98-105. PubMed ID: 11382926 [TBL] [Abstract][Full Text] [Related]
5. Transcription factor NF-kappaB differentially regulates death receptor 5 expression involving histone deacetylase 1. Shetty S; Graham BA; Brown JG; Hu X; Vegh-Yarema N; Harding G; Paul JT; Gibson SB Mol Cell Biol; 2005 Jul; 25(13):5404-16. PubMed ID: 15964798 [TBL] [Abstract][Full Text] [Related]
6. Tissue specific expression of p53 target genes suggests a key role for KILLER/DR5 in p53-dependent apoptosis in vivo. Burns TF; Bernhard EJ; El-Deiry WS Oncogene; 2001 Aug; 20(34):4601-12. PubMed ID: 11498783 [TBL] [Abstract][Full Text] [Related]
7. Induction of the TRAIL receptor KILLER/DR5 in p53-dependent apoptosis but not growth arrest. Wu GS; Burns TF; McDonald ER; Meng RD; Kao G; Muschel R; Yen T; el-Deiry WS Oncogene; 1999 Nov; 18(47):6411-8. PubMed ID: 10597242 [TBL] [Abstract][Full Text] [Related]
8. Molecular cloning and functional analysis of the mouse homologue of the KILLER/DR5 tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor. Wu GS; Burns TF; Zhan Y; Alnemri ES; El-Deiry WS Cancer Res; 1999 Jun; 59(12):2770-5. PubMed ID: 10383128 [TBL] [Abstract][Full Text] [Related]
9. Implication of p53 in growth arrest and apoptosis induced by the synthetic retinoid CD437 in human lung cancer cells. Sun SY; Yue P; Wu GS; El-Deiry WS; Shroot B; Hong WK; Lotan R Cancer Res; 1999 Jun; 59(12):2829-33. PubMed ID: 10383141 [TBL] [Abstract][Full Text] [Related]
10. Apo2 ligand/TNF-related apoptosis-inducing ligand and death receptor 5 mediate the apoptotic signaling induced by ionizing radiation in leukemic cells. Gong B; Almasan A Cancer Res; 2000 Oct; 60(20):5754-60. PubMed ID: 11059770 [TBL] [Abstract][Full Text] [Related]
11. Accelerated degradation of cellular FLIP protein through the ubiquitin-proteasome pathway in p53-mediated apoptosis of human cancer cells. Fukazawa T; Fujiwara T; Uno F; Teraishi F; Kadowaki Y; Itoshima T; Takata Y; Kagawa S; Roth JA; Tschopp J; Tanaka N Oncogene; 2001 Aug; 20(37):5225-31. PubMed ID: 11526513 [TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase 5 is not a p53 target gene, but its overexpression inhibits tumor cell growth and induces apoptosis. Huang Y; Tan M; Gosink M; Wang KK; Sun Y Cancer Res; 2002 May; 62(10):2913-22. PubMed ID: 12019172 [TBL] [Abstract][Full Text] [Related]
13. p53-dependent and -independent regulation of the death receptor KILLER/DR5 gene expression in response to genotoxic stress and tumor necrosis factor alpha. Sheikh MS; Burns TF; Huang Y; Wu GS; Amundson S; Brooks KS; Fornace AJ; el-Deiry WS Cancer Res; 1998 Apr; 58(8):1593-8. PubMed ID: 9563466 [TBL] [Abstract][Full Text] [Related]
14. Analysis of p53 transactivation through high-affinity binding sites. Chumakov AM; Miller CW; Chen DL; Koeffler HP Oncogene; 1993 Nov; 8(11):3005-11. PubMed ID: 8414502 [TBL] [Abstract][Full Text] [Related]
15. Induction of apoptosis by pectenotoxin-2 is mediated with the induction of DR4/DR5, Egr-1 and NAG-1, activation of caspases and modulation of the Bcl-2 family in p53-deficient Hep3B hepatocellular carcinoma cells. Shin DY; Kim GY; Kim ND; Jung JH; Kim SK; Kang HS; Choi YH Oncol Rep; 2008 Feb; 19(2):517-26. PubMed ID: 18202802 [TBL] [Abstract][Full Text] [Related]
16. CAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction is a major component of SHetA2-induced apoptosis in lung cancer cells. Lin YD; Chen S; Yue P; Zou W; Benbrook DM; Liu S; Le TC; Berlin KD; Khuri FR; Sun SY Cancer Res; 2008 Jul; 68(13):5335-44. PubMed ID: 18593935 [TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase inhibitors upregulate death receptor 5/TRAIL-R2 and sensitize apoptosis induced by TRAIL/APO2-L in human malignant tumor cells. Nakata S; Yoshida T; Horinaka M; Shiraishi T; Wakada M; Sakai T Oncogene; 2004 Aug; 23(37):6261-71. PubMed ID: 15208660 [TBL] [Abstract][Full Text] [Related]
18. Endoplasmic reticulum calcium pool depletion-induced apoptosis is coupled with activation of the death receptor 5 pathway. He Q; Lee DI; Rong R; Yu M; Luo X; Klein M; El-Deiry WS; Huang Y; Hussain A; Sheikh MS Oncogene; 2002 Apr; 21(17):2623-33. PubMed ID: 11965535 [TBL] [Abstract][Full Text] [Related]
19. The TRAIL decoy receptor TRUNDD (DcR2, TRAIL-R4) is induced by adenovirus-p53 overexpression and can delay TRAIL-, p53-, and KILLER/DR5-dependent colon cancer apoptosis. Meng RD; McDonald ER; Sheikh MS; Fornace AJ; El-Deiry WS Mol Ther; 2000 Feb; 1(2):130-44. PubMed ID: 10933923 [TBL] [Abstract][Full Text] [Related]
20. Rottlerin induces apoptosis via death receptor 5 (DR5) upregulation through CHOP-dependent and PKC delta-independent mechanism in human malignant tumor cells. Lim JH; Park JW; Choi KS; Park YB; Kwon TK Carcinogenesis; 2009 May; 30(5):729-36. PubMed ID: 19037087 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]